• Three Easy Steps to Complete your Onboarding: 

    1. Complete this Onboarding Request Form

    2. Schedule a Training Session with our team

    3. Submit the Credit Card Authorization Form

    We Look Forward to Serving you and your Patients! 

  • CLIENT ONBOARDING FORM

  • PRACTICE INFORMATION

  • Format: (000) 000-0000.
  • Format: (000) 000-0000.
  • PRESCRIPTION PREFERENCES

  • Preferred Prescription Method:*
  • Preferred Shipping Method:*
  • Do you have additional Prescribers you would like to add (in addition to the one referenced above)?*
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • PRICING CONFIRMATION FORM

  • Fulfillment Fee (including shipping): 

    Ship-to-Patient: $30 2-Day Shipping | $50 Next day shipping.

    (Please note that all patient-specific shipments are shipped using highest quality ice and insulated packaging. While medications are still usable at extreme tempratures, sometimes during summer months patients request re-shipments for medications that are delivered with melted ice packs when a 2-day shipment option is used. The customer is responsible for the cost of any such re-shipments. You may opt-in for next-day shipping to avoid such issues, at your descretion.)

    Ship-to-Clinic: $10 per Script (includes next day shipping). For orders greater than 200 vials, you may reach out to your sales rep for discounts!

    Please note that there is no extra charge for Saturday delivery!

  • Default Ship-to-Patient Option (if applicable):
  • Important Disclosures:

    While we seek to provide excellent service to every client, we would like to share with you some of the policies we have in place for transparency and ensuring we meet your expectations:

    1. Our default shipment method for ship-to-patient orders is a 2-day air shipment. Packages are placed in an insulated mailer with ice packs, sometimes (especially during summer months) the medication may arrive warm or at room temperature prompting the patient to request a re-shipment. Please note that the GLP-1 medications supplied by us have temperature studies that allow them to be shipped at room temperature and last for a number of hours even at extreme temperatures of over 104 degrees. We can provide you the temperature studies that could be provided to the patients upon request. Please note that the pharmacy will not be able to cover the cost of any re-ship requests should such issues arise. Clients may opt-in to use overnight shipping for their patients if they so elect.
    2. All shipments will be sent to the address provided by the client. While we verify the address before sending using an automated system, the pharmacy is not able to assume responsibility for any delivery issues such as missing unit numbers, lost or stolen packages or packages getting left outside for extended periods of time.
    3. All orders will be processed as they are received. As a general matter we cannot commit to expediting any orders outside of the order processing workflow. Should there be a need for expediting an order, please reach out to our customer service team. While we will do our best to assist in such situations, we cannot promise that such expedite requests can be satisfied.
  • I hereby confirm that the above referenced pricing and terms are acceptable. 

  • PHARMACY SERVICES AGREEMENT

  • This PHARMACY SERVICES AGREEMENT (the "Agreement") is executed as of the date set forth below ("Effective Date") by and between Quaker Community Pharmacy LLC, DBA NewLife Rx, and its "Affiliates" ("NewLife") and the counterparty set forth below located at the address set forth below ("Partner" Partner, a physician clinic, seeks to contract with NewLife Rx to provide "Pharmacy Services" to its "Customers"; NewLife Rx, an online pharmacy, desires to provide such Pharmacy Services to Customers; and now therefore, in consideration of the mutual promises and covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

    1. Customer Interface. Partner shall complete NewLife Rx's Practice Onboarding Form. Partner shall manage direct interface with its Customers, including payment collection, and shall send Customer prescription(s) for "Products" (as defined in Exhibit A) via e-Script or e-fax to NewLife Rx. Each prescription shall include Partner's name and pertinent information needed to establish accurate order creation and Customer records by NewLife Rx, including Customer name, DOB, phone #, Email, delivery address, and "Patient Status" (other medications taken, health conditions, allergies, etc Each party shall maintain the capability to send, receive, display, and print electronic messages with each other. NewLife Rx shall provide a toll-free number that will be accessible to Partner and/or Customers to use Pharmacy Services.

    2. Licenses. During the Term, NewLife Rx shall obtain and maintain all federal, state and local approvals, licenses, accreditation, permits and certifications required to operate as a pharmacy at each location where it does business.

    3. Dispensing. NewLife Rx shall fill prescriptions received from Partner's licensed prescribers in a compliant manner by dispensing and delivering fulfilled orders within a reasonable time directly to Customers to their designated delivery addresses. NewLife Rx may reach out to the prescriber, Partner, and/or Customer as needed to resolve any prescription related questions. Partner shall familiarize and confirm that end user patient agrees to NewLife Rx customer terms and conditions (for latest version visit https://www.NewLife Rxhealth.com/termsconditions NewLife Rx shall have licensed pharmacist(s) available to provide patient counseling during its normal business hours. The dispensing pharmacist, as per his/her best independent professional judgment, may choose to dispense, or refuse to dispense, any prescription based on such judgment and if latter, NewLife Rx shall notify Partner.

    4. Ordering. Partner shall bundle NewLife Rx Pharmacy Services to appropriately targeted Customers, familiarize them with NewLife Rx's customer terms and conditions, make full payment for all NewLife Rx Pharmacy Services invoiced relating to Product prescriptions sent to NewLife Rx by Partner's licensed prescribers. Partner shall be responsible for updating NewLife Rx of any change in Patient Status.

    5. Invoicing. For Pharmacy Services performed under this Agreement, NewLife Rx shall charge Partner's credit card on file prior to each Customer shipment. Partner shall pay NewLife Rx the Product Prices (as detailed in Onboarding Document) plus any applicable taxes. If the prescriber requests expedited shipment in the prescription, NewLife Rx will charge the incremental shipping costs to the credit card.

    6. Term. The Term of this Agreement shall be one (1) year from the Effective Date, with automatic monthly renewal ("Term") thereafter unless either party gives a ninety (90)-day written termination notice prior to the renewal date.

    7. Representations. Each party represents and warrants as of the Effective Date: 1) it operates in good standing and is duly licensed/authorized to perform its obligations under this Agreement, 2) none of its owners, shareholders, employees or agents has ever been convicted of a felony or any health care related crime, and have never been a "sanctioned person" within the meaning of section 1128(b) of the Social Security Act; and 3) to its knowledge, is not the subject of any governmental or regulatory agency investigation.

    8. Indemnification. Each party agrees to indemnify, defend, and hold harmless the other party and its officers, directors, managers, owners and employees from and against any and all third party claims, or causes of actions for damages, liabilities (including, without limitation, strict liability), penalties, costs and expenses (including, without limitation, attorneys' fees, expenses and costs) to the extent caused by: (i) the negligence or willful misconduct of the party or any of its officers, directors or employees in connection with the performance of this Agreement, or (ii) any breach of any representation, warranty or covenant under this Agreement by the party or its directors, officers or employees.

    9. Additional Terms. The Partner shall ensure that all prescriptions submitted to NewLife Rx comply with federal and state laws. If the Partner opts to pay via credit card,a 3% processing fee will be applied. NewLife Rx is not liable for theft of medication from a home or clinic after delivery. Damaged or broken vials will be handled on a case-by-case basis and will be reshipped if proof of product damage is sent via picture to NewLife Rx. The Partner is responsible for ensuring the accuracy of shipping addresses, prescriptions, and other required documentation. NewLife Rx is not liable for delays or issues arising from inaccurate or incomplete information provided by the Partner. The Partner agrees to review all orders carefully before submission to avoid cancellations or errors. Once an order is submitted and processing begins, NewLife Rx cannot guarantee cancellations or refunds. If payment is not received or is declined on the scheduled billing date, all shipments will be suspended until full payment is made.

    10. Governing Law. The Agreement shall be governed by and construed/interpreted/enforced accordance with the laws of the State of Delaware, without regard to any conflict of law or choice of laws provision.

    11. Acknowledgments. Partner acknowledges and agrees to NewLife Rx's additional Terms & Conditions for Pharmacy Services (which can be accessed by visiting https://www.NewLife Rxhealth.com/partnertermsconditions Any and all payments, notices, designations, consents, offers, acceptances or communication shall be in writing, addressed to the signatories below or other persons designated in writing.

    IN WITNESS WHEREOF the Parties hereto have executed this Agreement and made it effective as of the date set forth below.

  • Date*
     - -
    2 digit month, 2 digit day, 4 digit year
  • DiRx, Inc.

  • Image field 38
  • Signer's Name: Satish Srinivasan

    Signer's Title: CEO

  • HIPAA BUSINESS ASSOCIATE AGREEMENT

  • This Business Associate Agreement ("BAA") is entered into and effective on this day of ("Effective Date") by and between DiRx, Inc. and NewLife LLC (each, a "Covered Entity") and the business associate listed below ("Business Associate") (each a "Party" and collectively, the "Parties").

    RECITALS

    WHEREAS, Covered Entity is a "Covered Entity" as that term is defined under the Health Insurance Portability and Accountability Act of 1996 (Public Law 104-91), as amended, ("HIPAA"), and the regulations promulgated thereunder by the Secretary of the U.S. Department of Health and Human Services ("Secretary"), including, without limitation, the regulations codified at 45 C.F.R. Parts 160 and 164 ("HIPAA Regulations");

    WHEREAS, Business Associate seeks to perform Services for or on behalf of Covered Entity, and in performing said Services, Business Associate will create, receive, maintain, or transmit Protected Health Information ("PHI") or Electronic Protected Health Information ("ePHI"); and

    WHEREAS, the parties intend to protect the privacy and provide for the security of PHI and ePHI disclosed by Covered Entity to Business Associate, or received or created by Business Associate, when providing Services in compliance with the HIPAA Act, the HIPAA regulations, the Health Information Technology for Economic and Clinical Health Act ("the HITECH Act"), and all other applicable state and federal laws, all as amended from time to time.

    WHEREAS, Covered Entity is required under HIPAA to enter into a Business Associate Agreement (BAA) with Business Associate that meets certain requirements with respect to the use and disclosure of PHI.

    AGREEMENT

    In consideration of the above Recitals and for other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the Parties agree as follows:

    ARTICLE I: DEFINITIONS

    The following terms shall have the meanings set forth below. Capitalized terms used in this BAA and not otherwise defined shall have the meanings ascribed to them in HIPAA, the HIPAA Regulations, or the HITECH Act, as applicable.

    1.1. "Breach" shall have the meaning given under 42 U.S.C. § 17921(1) and 45 C.F.R. § 164.402.

    1.2. "Data Aggregation" shall have the meaning given under 45 C.F.R. § 164.501.

    1.3. "Designated Record Set" shall have the meaning given such term under 45 C.F.R. § 164.501.

    1.4. "Disclose" and "Disclosure" mean, with respect to PHI, the release, transfer, provision of access to, or divulging in any other manner of PHI outside of Business Associate or to other than members of its Workforce, as set forth in 45 C.F.R. § 160.103.

    1.5. "Electronic PHI" or "ePHI" means PHI that is transmitted or maintained in electronic media, as set forth in 45 C.F.R. § 160.103.

    1.6. "Protected Health Information" and "PHI" mean any information, whether oral or recorded in any form or medium, that: (a) relates to the past, present, or future physical or mental health or condition of an individual; the provision of health care to an individual; or the past, present, or future payment for the provision of health care to an individual; and that (b) identifies the individual, or for which there is a reasonable basis for believing that the information can be used to identify the individual. "Protected Health Information" shall have the meaning given to such term under 45 C.F.R. § 160.103. Under 45 C.F.R. § 160.103, Protected Health Information includes Electronic Protected Health Information (ePHI).

    1.7. "Security Incident" shall have the meaning given to such term under 45 C.F.R. § 164.304.

    1.8. "Services" shall mean the services for or functions performed by Business Associate on behalf of Covered Entity pursuant to any service agreement(s) between Covered Entity and Business Associates which may be in effect now or from time to time ("Underlying Agreement"), or, if no such agreement is in effect, the services or functions performed by Business Associate that constitute a Business Associate relationship, as set forth in 45 C.F.R. § 160.103, Definition of "Business Associate."

    1.9. "Subcontractor" A subcontractor means a person or entity to whom a Business Associate delegates a function, activity, or service, other than in the capacity of a member of the Workforce of such Business Associate.

    1.10. "Unsecured PHI" shall have the meaning given to such term under 42 U.S.C. § 17932(h), 45 C.F.R. § 164.402, and Federal Register documents, including, but not limited to, Federal Register document 74; Federal Register 19006 (April 27, 2009); and 78 Federal Register 5565 (January 25, 2013).

    1.11. "Use" or "Uses" mean, with respect to PHI, the sharing, employment, application, utilization, examination, or analysis of such PHI within Business Associate's internal operations, as set forth in 45 C.F.R. § 160.103. 1.12. "Workforce" shall have the meaning given to such term under 45 C.F.R. § 160.103.

    ARTICLE II: OBLIGATIONS OF BUSINESS ASSOCIATE

    2.1. Permitted Uses and Disclosures of Protected Health Information: Business Associate shall not use or disclose PHI other than for the purposes of performing the Services, as permitted or required by this BAA, or as required by law. Business Associate shall not use or disclose PHI in any manner that would constitute a violation of Subpart E of 45 C.F.R. Part 164 if so used or disclosed by Covered Entity. However, Business Associate may use or disclose PHI (i) for the proper management and administration of Business Associate; (ii) to carry out the legal responsibilities of Business Associate, provided that with respect to any such disclosure either: (a) the disclosure is required by law; or (b) Business Associate obtains a written agreement from the person to whom the PHI is to be disclosed that such person will hold the PHI in confidence and will not use or further disclose such PHI except as required by law and for the purpose(s) for which it was disclosed by Business Associate to such person, and that such person will notify Business Associate of any instances of which it is aware in which the confidentiality of the PHI has been breached; and (iii) pursuant to 45 C.F.R. § 164.501, for Data Aggregation purposes for the healthcare operations of Covered Entity. To the extent that Business Associate carries out one or more of Covered Entity's obligations under Subpart E of 45 C.F.R. Part 164, Business Associate must comply with the requirements of Subpart E that apply to the Covered Entity in the performance of such obligations.

    2.2. Prohibited Marketing and Sale of PHI: Notwithstanding any other provision in this BAA, Business Associate shall comply with the following requirements: (i) Business Associate shall not use or disclose PHI for fundraising or marketing purposes, except to the extent expressly authorized or permitted by this BAA and consistent with the requirements of 42 U.S.C. § 17936, 45 C.F.R. § 164.514(f), and 45 C.F.R. § 164.508(a3ii); and (ii) Business Associate shall not directly or indirectly receive remuneration in exchange for PHI, except with the prior written consent of Covered Entity and as permitted by the HITECH Act, 42 U.S.C. § 17935(d2), and 45 C.F.R. § 164.502(a)(5)(ii).

    2.3. Adequate Safeguards of PHI: Business Associate shall implement and maintain appropriate safeguards to prevent use or disclosure of PHI other than as provided for by this BAA. Business Associate shall reasonably and appropriately protect the confidentiality, integrity, and availability of ePHI that it creates, receives, maintains, or transmits on behalf of Covered Entity in compliance with Subpart C of 45 C.F.R. Part 164 to prevent use or disclosure of PHI other than as provided for by this BAA.

    2.4 Mitigation: Business Associate agrees to mitigate, to the extent practicable, any harmful effect that is known to Business Associate of a use or disclosure of PHI by Business Associate in violation of the requirements of this BAA.

    2.5. Reporting Non-Permitted Use or Disclosure:

    2.5.1 Reporting Security Incidents and Non-Permitted Use or Disclosure: Business Associate shall report to Covered Entity in writing each security incident or use or disclosure that is made by Business Associate, members of its workforce, or subcontractors that is not specifically permitted by this BAA, no later than three (3) business days after becoming aware of such security incident or non-permitted use or disclosure, in accordance with the notice provisions set forth herein. Business Associate shall investigate each security incident or non-permitted use or disclosure of Covered Entity's PHI that it discovers, to determine whether such security incident or non-permitted use or disclosure constitutes a reportable breach of unsecured PHI. Business Associate shall document and retain records of its investigation of any breach, including its reports to Covered Entity under this Section 2.5.1. Upon request of Covered Entity, Business Associate shall furnish to Covered Entity the documentation of its investigation and an assessment of whether such security incident or non-permitted use or disclosure constitutes a reportable breach. If such security incident or non-permitted use or disclosure constitutes a reportable breach of unsecured PHI, then Business Associate shall comply with the additional requirements of Section 2.5.2 below.

    2.5.2 Breach of Unsecured PHI: If Business Associate determines that a reportable breach of unsecured PHI has occurred, Business Associate shall provide a written report to Covered Entity without unreasonable delay, but no later than thirty (30) calendar days after discovery of the breach. To the extent that information is available to Business Associate, Business Associate's written report to Covered Entity shall be in accordance with 45 C.F.R. 164.410(c Business Associate shall cooperate with Covered Entity in meeting Covered Entity's obligations under HIPAA and the HITECH Act with respect to such breach. Covered Entity shall have sole control over the timing and method of providing notification of such breach to the affected individual(s), the HHS Secretary and, if applicable, the media, as required by HIPAA and the HITECH Act. Business Associate shall reimburse Covered Entity for its reasonable costs and expenses in providing the notification, including, but not limited to, any administrative costs associated with providing notice, printing and mailing costs, and costs of mitigating the harm (which may include the costs of obtaining credit monitoring services and identity theft insurance) for affected individuals whose PHI has or may have been compromised as a result of the breach. 

    2.5.3 Law Enforcement Delay: Business Associate may delay the notification required by Paragraph 2.5.2 if a law enforcement official states to Business Associate that notification would impede a criminal investigation or cause damage to national security. If the law enforcement official's statement is in writing and specifies the time for which a delay is required, Business Associate shall delay notification, notice, or posting for the time period specified by the official, and provide the covered entity with a copy of the written statement. If the statement is made orally, Business Associate shall document the statement, including the identity of the official making the statement, notify the covered entity of the contents of the statement, and delay notification, notice, or posting temporarily and no longer than 30 days from the state of the oral statement, unless a written statement is submitted during that time.

    2.6. Availability of Internal Practices, Books. and Records to Government: Business Associate agrees to make its internal practices, books, and records relating to the use and disclosure of PHI received from, created, or received by the Business Associate on behalf of Covered Entity available to the Secretary for purposes of determining Covered Entity's compliance with HIPAA, the HIPAA Regulations, and the HITECH Act. Except to the extent prohibited by law, Business Associate shall notify Covered Entity of all requests served upon Business Associate for information or documentation by or on behalf of the Secretary. Business Associate agrees to provide to Covered Entity proof of its compliance with the HIPAA Security Standards. 

    2.7. Access to and Amendment of Protected Health Information: To the extent that Business Associate maintains a Designated Record Set on behalf of Covered Entity and within fifteen (15) days of a request by Covered Entity, Business Associate shall (a) make the PHI it maintains (or which is maintained by its Subcontractors) in Designated Record Sets available to Covered Entity for inspection and copying, or to an individual to enable Covered Entity to fulfill its obligations under 45 C.F.R. § 164.524, or (b) amend the PHIit maintains (or which is maintained by its Subcontractors) in Designated Record Sets to enable the Covered Entity to fulfill its obligations under 45 C.F.R. § 164.526. Business Associate shall not Disclose PHI to a health plan for payment or Health Care Operations purposes if and to the extent that Covered Entity has informed Business Associate that the patient has requested this special restriction, and has paid out of pocket in full for the health care item or service to which the PHI solely relates, consistent with 42 U.S.C. § 17935(a) and 42 C.F.R. § 164.522(a1vi If Business Associate maintains PHI in a Designated Record Set electronically, Business Associate shall provide such information in the electronic form and format requested by the Covered Entity if it is readily reproducible in such form and format, and, if not, in such other form and format agreed to by Covered Entity to enable Covered Entity to fulfill its obligations under 42 U.S.C. § 17935(e) and 45 C.F.R. § 164.524(c2 Business Associate shall notify Covered Entity within fifteen (15) days of receipt of a request for access to PHI.

    2.8. Accounting: To the extent that Business Associate maintains a Designated Record Set on behalf of Covered Entity, within thirty (30) days of receipt of a request from Covered Entity or an individual for an accounting of disclosures of PHI, Business Associate and its Subcontractors shall make available to Covered Entity the information required to provide an accounting of disclosures to enable Covered Entity to fulfill its obligations under 45 C.F.R. § 164.528 and its obligations under 42 U.S.C. § 17935(c Business Associate shall notify Covered Entity within fifteen (15) days of receipt of a request by an individual or other requesting party for an accounting of disclosures of PHI. 

    2.9. Use of Subcontractors: Business Associate shall require each of its Subcontractors that creates, maintains, receives, or transmits PHI on behalf of Business Associate, to execute a Business Associate Agreement that imposes on such Subcontractors the same restrictions, conditions, and requirements that apply to Business Associate under this BAA with respect to PHI. 

    2.10. Minimum Necessary: Business Associate (and its Subcontractors) shall, to the extent practicable, limit its request, use, or disclosure of PHI to the minimum amount of PHI necessary to accomplish the purpose of the request, use, or disclosure, in accordance with 42 U.S.C. § 17935(b) and 45 C.F.R. § 164.502(b)(1) or any other guidance issued thereunder.

    ARTICLE III: TERM AND TERMINATION

    3.1. Term: The term of this Agreement shall be effective as of the Effective Date and shall terminate as of the date that all of the PHI provided by Covered Entity to Business Associate, created, or received by Business Associate on behalf of Covered Entity, is destroyed or returned to Covered Entity, or, if it is infeasible to return or destroy the PHI, protections are extended to such information, in accordance with Section 3.3, or on the date that Covered Entity terminates for cause as authorized in Section 3.2, whichever is sooner.

    3.2. Termination for Cause: Upon Covered Entity's knowledge of a material breach or violation of this BAA by Business Associate, Covered Entity shall either: 1. Notify Business Associate of the breach in writing, and provide an opportunity for Business Associate to cure the breach or end the violation within ten (10) business days of such notification; provided that if Business Associate fails to cure the breach or end the violation within such time period to the satisfaction of Covered Entity, Covered Entity may immediately terminate this BAA upon written notice to Business Associate; or 2. Upon written notice to Business Associate, immediately terminate this BAA if Covered Entity determines that such breach cannot be cured.

    3.3. Disposition of Protected Health Information Upon Termination or Expiration:

    3.3.1. Upon termination or expiration of this BAA, Business Associate shall either return or destroy all PHI received from, created, or received by Business Associate on behalf of Covered Entity, that Business Associate still maintains in any form and retain no copies of such PHI. If Covered Entity requests that Business Associate return PHI, PHI shall be returned in a mutually agreed upon format and timeframe, at no additional charge to Covered Entity.

    3.3.2. If return or destruction is not feasible, Business Associate shall (a) retain only that PHI which is necessary for Business Associate to continue its proper management and administration or to carry out its legal responsibilities; (b) return to Covered Entity the remaining PHI that Business Associate still maintains in any form; (c) continue to extend the protections of this BAA to the PHI for as long as Business Associate retains the PHI; (d) limit further Uses and Disclosures of such PHI to those purposes that make the return or destruction of the PHI infeasible and subject to the same conditions set out in Section 2.1 and 2.2 above, which applied prior to termination; and (e) return to Covered Entity the PHI retained by Business Associate when it is no longer needed by Business Associate for its proper management and administration or to carry out its legal responsibilities.

    ARTICLE IV: MISCELLANEOUS

    4.1. Amendment to Comply with Law: This BAA shall be deemed amended to incorporate any mandatory obligations of Covered Entity or Business Associate under the HITECH Act and its implementing HIPAA Regulations. Additionally, the Parties agree to take such action as is necessary to amend this BAA from time to time as necessary for Covered Entity to implement its obligations pursuant to HIPAA, the HIPAA Regulations, or the HITECH Act.

    4.2. Indemnification: Both companies/organizations (Covered Entity and/or Business Associate(s hereby agree to indemnify and hold harmless the other, its affiliates, and their respective officers, directors, managers, members, shareholders, employees, and agents from and against any and all fines, penalties, damage, claims, or causes of action and expenses (including, without limitation, court costs, and attorney's fees) the companies/organizations incur, arising from violations of the HIPAA Act, the HIPAA Regulations, the HITECH Act, or from any negligence or wrongful acts or omissions, including, but not limited to, failure to perform its obligations that results in a violation of the HIPAA Act the HIPAA Regulations, or the HITECH Act, by either company/organization or its employees, directors, officers, subcontractors, agents, or members of its Workforce.

    4.3. Notices: Any notices required or permitted to be given hereunder by either Party to the other shall be given in writing: (1) by personal delivery; (2) by electronic mail or facsimile with confirmation sent by United States first class registered or certified mail, postage prepaid, return receipt requested; (3) by bonded courier or by a nationally recognized overnight delivery service; or (4) by United States first class registered or certified mail, postage prepaid, return receipt, in each case, addressed to a Party on the signature page(s) to this Agreement or to such other addresses as the Parties may request in writing by notice given pursuant to this Section 4.3. Notices shall be deemed received on the earliest of personal delivery; upon delivery by electronic facsimile with confirmation from the transmitting machine that the transmission was completed; twenty-four (24) hours following deposit with a bonded courier or overnight delivery service; or seventy-two (72) hours following deposit in the U.S. mail as required herein.

    4.4. Relationship of Parties: Business Associate is an independent contractor and not an agent of Covered Entity under this BAA. Business Associate has the sole right and obligation to supervise, manage, contract, direct, procure, perform, or cause to be performed, all Business Associate obligations under this BAA.

    4.5. Survival: The respective rights and obligations of the Parties under Sections 3.3 and 4.2 of this BAA shall survive the termination of this BAA.

    4.6 Applicable Law and Venue: This Agreement shall be governed by and construed in accordance with the laws of the state of Delaware (without regards to conflict of laws principles The Parties agree that all actions or proceedings arising in connection with this BAA shall be tried and litigated exclusively in the state or federal (if permitted by law and if a Party elects to file an action in federal court) courts located in the state of Delaware.

    The Parties hereto have duly executed this agreement as of the date set forth.

  • Date*
     / /
    2 digit month, 2 digit day, 4 digit year
  • Covered Entity Legal Name:

    NewLife LLC

  • Image field 56
  • Signer's Name: Ramin Montazeri

    Signer's Title: CEO

  • Notice Address:

    NewLife LLC,  220 Technology, Suite 215 Irvine, CA 92618

    Attention: Ramin Montazeri

    Email: hq@newliferx.us

  • Covered Entity Legal Name:

    DiRx, Inc.

  • Image field 55
  • Signer's Name: Satish Srinivasan

    Signer's Title: CEO

  • Notice Address:

    DiRx, Inc. 1 Tower Center Blvd, #23 East Brunswick, NJ 08816

    Attention: Satish Srinivasan

    Email: satish.srinivasan@dirxhealth.com

  • Up Next: Schedule Your Training Session!

  • NewLifeRX

  • Should be Empty: